Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapentadol ER for Chronic Pain in Japanese Subjects
NCT01124617Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jun 2010
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetic peripheral neuropathy (DPN) and postherpetic neuralgia (PHN) comparing Tapentadol ER with Placebo (2 arms). Primary endpoint: Change From Baseline in Average Numerical Rating Scale Score at 12 weeks. Started Jun 2010; status: completed.
02
Drugs
tapentadol
03
Conditions
diabetic peripheral neuropathy (DPN)postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT01124617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01124617.